CTXR - CIK 0001506251
The table below shows Citius Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.25M | $3.25M | $26.48M | $41.71M | $70.07M | $13.86M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $22.29M | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $27.93M |
| $14.22M |
| $34.37M |
| $44.56M |
| $72.81M |
| $13.98M |
| Property, plant & equipment | - | $1.43K | $1.43K | $4.10K | $7.02K | $1.58K |
| Goodwill | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M | $9.35M |
| Total assets | $130.94M | $116.65M | $103.61M | $114.00M | $142.43M | $43.77M |
| Accounts payable | $13.69M | $4.93M | $2.93M | $1.17M | $1.28M | $1.86M |
| Total current liabilities | $44.91M | $35.81M | $5.78M | $4.53M | $3.98M | $4.10M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $53.41M | $42.55M | $12.18M | $10.57M | $9.65M | $10.10M |
| Retained earnings | -$238.80M | -$201.37M | -$162.23M | -$129.69M | -$96.05M | -$70.59M |
| Total equity | $67.55M | $70.08M | $90.83M | $102.83M | $132.18M | $33.67M |